The Next Generation in Refractive Vision Correction
Market & Opportunity
Near-sightedness (e.g., myopia) is the world’s most common and fastest growing vision problem. The existing global refractive vision correction market is approximately $2B in annual revenue.
Crystilex™ is focused on treating myopia and mitigating the future onset of age-related (e.g., presbyopia) vision correction. The unique features of Crystilex™ also enable the correction of astigmatism and hyperopia.
Open your eyes with your newfound freedom with this technology
Crystilex™ represents a leap forward in refractive vision correction that provides a clinically superior outcome while addressing the drawbacks of previous generation products and procedures.